Xenetic BiosciencesXBIO

13F holders, Q4 2024 (December 31)
13holders +4
4new positions
2sold out
2famous investors
$3.98avg. 13F price*

At the end of Q4 2024, 13 institutions reported holding Xenetic Biosciences Inc. (XBIO) in their 13F filings, up 4 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were Renaissance Technologies ($102K), Susquehanna International Group, LLP ($64K) and Citadel Advisors ($54K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Xenetic Biosciences Inc.
CUSIP
984015602
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 7Q1 2024Q2 2024: 5Q2 2024Q3 2024: 9Q3 2024Q4 2024: 13Q4 2024Q1 2025: 13Q1 2025Q2 2025: 9Q2 2025Q3 2025: 10Q3 2025Q4 2025: 11Q4 2025Q1 2026: 6Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions4$166K
Exits2$4K

All 13F filers, Q3 2024 → Q4 2024: 51,595 shares bought and 10,910 shares sold, net +40,685 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 13 holders

Renaissance Technologies 0.00% Add +61.2% 25,550 $102K
Susquehanna International Group, LLP 0.00% New 15,859 $64K
Citadel Advisors 0.00% New 13,380 $54K
Geode Capital Management, LLC 0.00% No change 11,889 $48K
LGT Group Foundation 0.00% New 11,000 $41K
Sachetta, LLC 0.01% Reduce -57.6% 7,371 $29K
JTC Employer Solutions Trustee Ltd 0.00% No change 2,700 $11K
UBS Group AG 0.00% New 1,656 $7K
Alexis Investment Partners, LLC 0.00% — 25 $100
Bank of America Corp. 0.00% Reduce -62.1% 11 $44
SBI Securities Co., Ltd. 0.00% — 5 $20
Darwin Wealth Management, LLC 0.00% No change 2 $7
Morgan Stanley 0.00% No change 1 $4

"% of holder's portfolio" is XBIO's weight in each manager's 13F, not the share of Xenetic Biosciences Inc. the manager owns.